Safety During Clinical Trials is my Priority
Clients
Our Services
Phase I/IIa
We have an outstanding 20 years safe and compliant track record in early stage clinical trials.
Bioequivalence
We provide a wide range of services for bioequivalence and bioavailability studies to the generic industry.
505(b)(2)-Generic Hybrid
Through key alliances, our team of experts can help you design and conduct your 505(b)(2) study successfully.
Bioanalysis
Our bioanalytical facilities share more than 500 validated methods for drugs, metabolites and biomarkers.
-
Join us!
-
News
-
June 9-13, 2013
61st ASMS Conference on Mass Spectrometry and Allied Topics
Minneapolis, Minnesota, US -
June 11-14, 2013
CSPS Canadian Society for Pharmaceutical Sciences Annual Symposium
Vancouver, British Columbia, CA -
June 17-18, 2013
EUFEPS Forum - Revised European Guideline on Pharmacokinetic and Clinical Evaluation of Modified Release Dosage Forms
Bonn, DE -
June 24-26, 2013
DIA 2013 - 49th Annual Meeting
Boston, Massachusetts, US
-
05/14/2013
Vince and Associates Clinical Research Joins the Altasciences Group
Vince And Associates Press Release (May 14).pdf (308.09 KB)
Read More -
03/25/2013
SQI Diagnostics and Algorithme Pharma Provide Update on Multiplex Heparin Immunogenicity Assay
Read More -
02/14/2013
Lab Bio-Medic, Algorithme Pharma Sign Partnership
Press Release Partnership AlgoPharma-LBM February 14 2013.pdf (412.67 KB)
Read More -
01/28/2013
Algorithme Pharma and SQI Diagnostics to Develop Multiplex Heparin Immunogenicity Assay
Jan 25 2013 Algorithme Pharma - SQI Press Release FINAL.pdf (42.39 KB)
Read More -
06/28/2012
Algorithme Pharma - The Solution to your Most Complex PreClinical Bioanalysis Challenges
Bulletin-Preclinical.pdf (84.43 KB)
Read More -
04/25/2012
Increasingly Complex World of Early Drug Development
Early-drug-development.pdf (145.44 KB)
Read More -
03/29/2012
AB SCIEX QTRAP® 5500 LC/MS/MS System
AB-Sciex-QTrap.pdf (623.93 KB)
Read More -
02/22/2012
Ligand Binding Assays
Bulletin-Ligand-binding.pdf (134.09 KB)
Read More -
02/08/2012
Critical Outcome Technologies Inc. announced today it has engaged Algorithme Pharma Inc.
120208_COTI_COTI-2_detection.pdf (105.1 KB)
Read More -
02/08/2012
Sensitivity and Speed: Bioanalysis Development at Algorithme Pharma
Read More

